We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 4.00 | 1.93% | 211.50 | 211.50 | 214.00 | 214.00 | 200.00 | 200.00 | 809,873 | 16:35:05 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 29.23 | 464.83M |
From May 2019 to May 2024
TIDMAMS
RNS Number : 0863N
Advanced Medical Solutions Grp PLC
03 May 2018
3 May 2018
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR and PCA Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that the Trust which manages the Deferred Share Bonus Plan ("Plan") on behalf of the employees of AMS has purchased ordinary shares of 5 pence each ("Ordinary Shares") on 30 April 2018, at a price of 306.77p on behalf of Chris Meredith, Mary Tavener, Simon Coates, Rose Guang, Eddie Johnson, Becky Walmsley, Jeff Willis, Pieter van Hoof and Cathy Tomlinson ("PDMRs") as part of the Deferred Share Bonus Plan and, under the terms of the Plan, these shares will be held in trust on their behalf.
Following these transactions the beneficial ownership of the PDMRs is as follows:
Hot Features
Premium
Director/PDMR Date purchased Shares Resultant % of issued
purchased holding share capital
================== ================ =========== ========== ===============
Chris Meredith
Chief Executive 30 April
Officer 2018 2,316 1,484,395 0.697%
================== ================ =========== ========== ===============
Mary Tavener
Chief Financial 30 April
Officer 2018 586 1,960,277 0.920%
================== ================ =========== ========== ===============
Simon Coates 30 April
PDMR 2018 3,754 97,581 0.046%
================== ================ =========== ========== ===============
Rose Guang 30 April
PDMR 2018 6,670 42,729 0.020%
================== ================ =========== ========== ===============
Eddie Johnson 30 April
PDMR 2018 6,845 55,579 0.026%
================== ================ =========== ========== ===============
Becky Walmsley 30 April
PDMR 2018 2,419 5,888 0.003%
================== ================ =========== ========== ===============
Jeff Willis 30 April
PDMR 2018 4,057 165,396 0.078%
================== ================ =========== ========== ===============
Pieter van
Hoof 30 April
PDMR 2018 3,867 127,208 0.060%
================== ================ =========== ========== ===============
Cathy Tomlinson 30 April
PDMR 2018 4,458 4,458 0.002%
================== ================ =========== ========== ===============
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Chris Meredith
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: Director/PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 2,316 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- ---------------------------------------------------------
a) Name: Mary Tavener
--- ---------------------------------------------------------
2. Reason for the notification
--- ---------------------------------------------------------
a) Position/status: Director/PDMR
--- ---------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- ---------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- ---------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- ---------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- ---------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- ---------------------------------------------------------
b) Nature of the transactions:
* Purchase of 586 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- ---------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- ---------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- ---------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- ---------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- ---------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Simon Coates
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 3,754 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Rose Guang
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 6,670 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Eddie Johnson
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 6,845 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Becky Walmsley
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 2,419 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Jeff Willis
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 4,057 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Pieter van Hoof
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 3,867 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
1. Details of the person discharging managerial
responsibilities/person closely associated
--- -----------------------------------------------------------
a) Name: Cathy Tomlinson
--- -----------------------------------------------------------
2. Reason for the notification
--- -----------------------------------------------------------
a) Position/status: PDMR
--- -----------------------------------------------------------
b) Initial notification/Amendment: Initial
Notification
--- -----------------------------------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name: Advanced Medical Solutions Group
plc
--- -----------------------------------------------------------
b) LEI: 213800HJP6OWOSZI1L74
--- -----------------------------------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of the financial instrument,
type of instrument: Ordinary Shares of
5p
Identification code: GB0004536594
--- -----------------------------------------------------------
b) Nature of the transactions:
* Purchase of 4,458 Ordinary Shares as part of the
Deferred Share Bonus Plan on 30 April 2018
--- -----------------------------------------------------------
c) Price(s) and volume(s):
Sale of shares: Price(s) Volume(s)
--------- ----------
n/a n/a
--------- ----------
--- -----------------------------------------------------------
d) Aggregated information: (Relates to those
shares sold only)
Aggregated volume: n/a
Aggregated price: n/a
--- -----------------------------------------------------------
e) Date of the transaction: 30/04/2018
--- -----------------------------------------------------------
f) Place of the transaction: London Stock
Exchange, AIM Market (XLON)
--- -----------------------------------------------------------
- End -
For further information, please visit www.admedsol.com or contact:
Advanced Medical Solutions Group Tel: +44 (0)
plc 1606 545508
Chris Meredith, Chief Executive
Officer
Mary Tavener, Chief Financial
Officer
Consilium Strategic Communications Tel: +44 (0)
20 3709 5700
Mary-Jane Elliott / Matthew Neal AMS@consilium-comms.com
/ Philippa Gardner
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0)
20 7597 5970
Daniel Adams / Patrick Robb /
Gary Clarence
About Advanced Medical Solutions Group plc - see www.admedsol.com
AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 600 employees. For more information, please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLFIREAIVIIT
(END) Dow Jones Newswires
May 03, 2018 12:12 ET (16:12 GMT)
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
